UK-listed Poolbeg Pharma slides after equity placement priced at 16% discount

Poolbeg Pharma

14/07/2026 09:24

** Shares of clinical-stage biopharmaceutical company Poolbeg Pharma POLB.L fall 12.9% to 6.1 pence
** Co announces £3.5 million ($4.68 million) equity placement of 58.3 million new shares at 6 pence each
** Issue price represents a 16.08% discount to the 7.15 pence close on July 13
** YTD, stock up 55%

($1 = 0.7486 pounds)

 (Reporting by Anushka Chourasia in Bengaluru)
 ((Anushka.Chourasia@thomsonreuters.com))